Cite
APA Citation
Luo, X. D., Chen, X. F., Zhou, Y., & Chen, X. P. (n.d.). comparison of 208‐week sequential therapy with telbivudine and entecavir in HBeAg‐positive chronic hepatitis B patients with suboptimal responses to 24 weeks of Peg‐IFNα‐2a therapy: An open‐labelled, randomized, controlled, "real‐life" trial. Journal of viral hepatitis, 24, 36–42. http://access.bl.uk/ark:/81055/vdc_100052194102.0x000033